The relevance of increased inflammation parameters in the blood of glioma patients, such as erythrocyte sedimentation rate and C-reactive protein levels, has recently been reported10, and these parameters might collectively have a strong prognostic significance, as should be tested in further clinical studies, based on the criteria by Gautam et al.15 This evidence concerns the gene CRP and glioma.